1H 2017 Healthcare and Life Sciences Transaction Report

    Healthcare and Life Sciences companies raised over $105 billion in capital in the first half of 2017 reflecting a continued interest in the sector. Even though overall transaction activity decreased compared to the same period in 2016, corporate M&A, private equity, and follow-on transactions displayed spirited levels of investment.

    In this report, we analyze 2017 healthcare and technology transaction activity across a number of capital sources and provide our outlook for each capital source for the rest of this year.

    This has been prepared for information purposes and general guidance only and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is made as to the accuracy or completeness of the information contained in this publication, and CohnReznick LLP, its members, employees and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.